Impact of COVID-19 Pandemic on Allogeneic Stem Cell Transplantation Organization : a French Experience

NCT05088941 · clinicaltrials.gov ↗

COMPLETED

Status

89

Enrollment

OTHER

Sponsor class

Conditions

Allogeneic Stem Cell Transplantation
SARS-CoV2 Infection
COVID-19

Sponsor

Central Hospital, Nancy, France